Melanoma: Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma (Adv. Therap. 8/2020)
Advanced Therapeutics(2020)
摘要
In article number 2000028 Ronit Satchi-Fainaro and co-workers present a novel polymeric system that simultaneously delivers a combination of drugs that target BRAF/ MEK mutations in melanoma. This system possesses an improved solubility, stability, and selective release by cathepsins in the tumor site. Hence, it exhibits synergistic activity, with superior efficacy and safety compared to each monodrug polymer conjugate and combinations of the free drugs.
更多查看译文
关键词
melanoma,polyglutamic acid,mutated braf
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要